Healthcare & Life Sciences
Architect Therapeutics
United Stateswww.architecttherapeutics.com/
Architect Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Seed, 1 tracked investor.
seed
seed
Stage
1
Investors
About Architect Therapeutics
Architect Therapeutics is a company headquartered in the United States. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Architect Therapeutics uses C-H bond activation chemistry to design and synthesize novel 3D small molecule drug scaffolds targeting difficult-to-drug disease mechanisms, primarily focusing on immunology and oncology.
Explore Architect Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.